Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$2.03B |
 |
MedtronicMDT |
-$93M |
 |
Edwards LifesciencesEW |
-$364M |
 |
Intuitive SurgicalISRG |
-$1.36B |
 |
MedpaceMEDP |
-$66.9B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Sheridan John F | Aug 11, 2025 | Buy | 10,000 | $10.2318 | $100,000 |
| Vosseller Leigh | Aug 8, 2025 | Buy | 13,720 | $10.8895 | $150,000 |
| Kyrillos Jean-Claude | Mar 7, 2025 | Buy | 10,538 | $18.1217 | $190,000 |
| BLICKENSTAFF KIM D | Nov 21, 2024 | Sell | 30,000 | $31.38 | $940,000 |
| BLICKENSTAFF KIM D | Nov 20, 2024 | Sell | 10,000 | $30 | $300,000 |
| Novara Mark David | Nov 15, 2024 | Buy | 532 | $23.24 | $12,000 |
| Allen Dick | May 30, 2024 | Sell | 5,000 | $51.68 | $260,000 |
FAQ - Insider Transactions
The most recent insider transaction for Tandem Diabetes Care was conducted by Sheridan John F, who sold 10,000 shares on August 11, 2025 at a price of $10.23 per share.
Kyrillos Jean-Claude has bought the most TNDM stock in the last 2 years, with a total value of $190,000.
BLICKENSTAFF KIM D has sold the most TNDM stock in the last 2 years, with a total value of $1.2M.
The total value of insider transactions for Tandem Diabetes Care in the last 2 years is negative, amounting to -$1M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Tandem Diabetes Care have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
